Gene symbol and protein | Gene Location | All allelic disease phenotypes - locus/disease symbols |
FA2HFatty acid 2-hydroxylase     | 16q21-q23.1 | * Spastic paraplegia 35, autosomal recessive - SPG35 (15.41)
* Dysmyelinating leukodystrophy - FAHN (15.41)
|
FAM111BFamily with sequence similarity 111 member B     | 11q12.1 | * Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis - POIKTMP (17.37)
|
FARS2Phenylalanine-tRNA synthetase 2(M)     | 6p25.1 | * Spastic paraplegia 77, autosomal recessive - SPG77 (15.67)
|
FASTKD2Fast Kinase Domains 2     | 2q33.3 | * Combined oxidative phosphorylation deficiency 44 - COXPD44 (17.45)
|
FAT2Fat tumor suppressor, Drosophila, Homologh of, 2     | 5q33.1 | * Spinocerebellar ataxia 45 - SCA45 (13.41)
|
FBLN5Fibulin 5 (extra-cellular matrix)     | 14q32.12 | * Charcot-Marie-Tooth neuropathy, with fibulin defect - (14.9)
|
FBXL4F-box and leucine-rich repeat protein 4     | 6q16.1-q16.2 | * Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type) - MTDPS13 (17.43)
|
| 5q32 | * Distal Spinal Muscular Atrophy with Calf Predominance - HMN2D (12.28)
|
| 19p13.2 | * Mitochondrial myopathy, episodic with or withour atrophy and reversible leukoencephalopathy - MEOAL (16.30)
|
FGD4Actin-filament binding protein Frabin     | 12p11.21 | * Charcot-Marie-Tooth neuropathy Type 4H - CMT4H (14.32)
|
FGF14Fibroblast growth factor 14     | 13q34 | * Spinocerebellar ataxia 27 - SCA27 (13.24)
|
FHL1Four and a half LIM domain 1     | Xq26.3 | * Scapuloperoneal myopathy, X-linked dominant - SPM (1.7, 5.33, 5.34, 5.35)
* Emery-dreifuss muscular dystrophy 6 - EDMD6 (1.7, 5.33, 5.34, 5.35)
* X-linked myopathy with postural muscle atrophy - XMPMA (1.7, 5.33, 5.34, 5.35)
* Myopathy, reducing body, X-linked, childhood-onset - (1.7, 5.33, 5.34, 5.35) * Rigid spine syndrome related to FHL1 - RSS (1.7, 5.33, 5.34, 5.35)
* Myopathy, reducing body, X-linked, severe early-onset - (1.7, 5.33, 5.34, 5.35)
* Rigid spine syndrome - RSMD1 (1.7, 5.33, 5.34, 5.35)
|
FHOD3Formin homology-2 domain-containing protein 3     | 18q12.2 | * Hypertrophic cardiomyopathy, 28 - CMH28 (10.30)
|
FICDFIC domain-containing protein adenylyltransferase     | 12q23.3 | * Spastic paraplegia 92, autosomal recessive - SPG92 (15.81)
|
FIG4Sac domain-containing inositol phosphatase 3     | 6q21 | * charcot-marie-tooth disease, type 4j - CMT4J (12.64, 14.33)
* Amyotrophic lateral sclerosis 11 - ALS11 (12.64, 14.33)
|
FILIP1Filamin A-interacting protein 1     | 6q14.1 | * Neuromuscular disorder, congenital, with dysmorphic facies - NMDF (5.17)
|
FKRPFukutin-related protein     | 19q13.32 | * Walker-Warburg syndrome - WWS (1.47, 2.23, 2.37) * Muscle-eye-brain disease - MEB (1.47, 2.23, 2.37)
* Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA5 (1.47, 2.23, 2.37)
* Muscular dystrophy-dystroglycanopathy (congenital with or without mental retarda - MDDGB5 (1.47, 2.23, 2.37)
* Muscular dystrophy, limb-girdle, type 2I - LGMD2I (1.47, 2.23, 2.37)
|
| 9q31-q33 | * Walker-Warburg syndrome - WWS (1.46, 2.22, 2.36, 10.61)
* Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), t - MDDGB4 (1.46, 2.22, 2.36, 10.61)
* fukuyama congenital muscular dystrophy - FCMD (1.46, 2.22, 2.36, 10.61)
* Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), - MDDGA4 (1.46, 2.22, 2.36, 10.61)
* Cardiomyopathy, dilated, 1X - CMD1X (1.46, 2.22, 2.36, 10.61)
* Limb-Girdle, Muscular dystrophy, type 2M - LGMD2M (1.46, 2.22, 2.36, 10.61)
|
FLAD1flavin adenine dinucleotide synthetase, homolog(M)     | 1q21.3 | * Lipid storage myopathy due to Flavin Adenine Dinucleotide Synthetase Deficiency - LSMFLAD (9.34)
|
FLIIFLII actin remodeling protein     | 17p11.2 | * Dilated cardiomyopathy, 2H - CMD2H (10.89)
|
FLNAFilamin A, alpha (actin binding protein 280)      | Xq28 | * Myxomatous valvular dystrophy, X-ninked - XMVD (10.114)
* cardiac valvular dysplasia, x-linked - CVD1 (10.114)
|
FLNCFilamin C, gamma (actin-binding protein - 280)     | 7q32 | * Myopathy, myofibrillar, filamin C-related - MFM5 (4.8, 5.6, 10.100, 10.28)
* Myopathy, distal, 4 - MPD4 (4.8, 5.6, 10.100, 10.28)
* Cardiomyopathy, familial hypertrophic, 26 - CMH26 (4.8, 5.6, 10.100, 10.28)
|
FLVCR1Feline leukemia subgroup C receptor 1     | 1q32.3 | * Ataxia, posterior column, with retinitis pigmentosa (PCARP) - AXPC1 (14.119)
|
FUSFusion (involved in t(12;16) in malignant liposarcoma)     | 16q12 | * Amyotrophic lateral sclerosis - ALS6 (12.59)
|
| 9q13-q21.1 | * Friedreich ataxia - FRDA (13.57)
* Friedreich ataxia with retained reflexes - FARR (13.57)
|
FXR1FMR1 autosomal homolog      | 3q26.33 | * Congenital myopathy 9A - CMYP9A (3.49, 3.50)
* Congenital myopathy 9B, proximal with minicore - CMYP9B (3.49, 3.50)
|